Inventor · disambiguated record
Philippe Marcel Nuhant
Also filed as: NUHANT PHILIPPE MARCEL
6 granted patents·5 pending applications·13 citations·filing 2019–2023
77Inventor score
Top patents by PatentIndex Score
11 records- 0191US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0290US11708360B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 0389US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 0488US10975065B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2019·Granted Apr 13, 2021·3 cites·14 claims
- 0580US12312344B2N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitorsPFIZER·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 0679US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 0768US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0853US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0953US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1052US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1152US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →